PFE

Pfizer Inc

30.11

Oct 20 • 3:59 PM ET +0.67 (2.28%)

29.99

Aftermarket • 6:16 PM ET -0.12 (-0.39%)

Healthcare Drug Manufacturers - General USA Large NYSE

Peers: GSK AZN BMY MRK SNY NVS ABBV JNJ AMGN LLY

| Held by: VTI VOO IVV SPY VTV XLV HDV HDV VYM DVY

Scroll to Statements

Index	S&P 500
Market Cap	171.62B
Enterprise Value	223.41B
Income	4.33B
Sales	63.70B
Book/sh	14.95
Cash/sh	2.05
Dividend Est.	1.72 (5.72%)
Dividend TTM	1.72 (5.71%)
Dividend Ex-Date	Nov 06, 2026
Dividend Gr. 3/5Y	2.23% 2.37%
Payout	126.85%
Employees	75000
IPO	Jan 17, 1944

P/E	39.87
Forward P/E	10.39
PEG	-
P/S	2.69
P/B	2.01
P/C	14.67
P/FCF	15.62
EV/EBITDA	9.50
EV/Sales	3.51
Quick Ratio	0.96
Current Ratio	1.27
Debt/Eq	0.74
LT Debt/Eq	0.71
Option/Short	Yes / Yes

EPS (ttm)	0.76
EPS next Y	2.90
EPS next Q	0.73
EPS this Y	-8.07%
EPS next Y	-2.08%
EPS next 5Y	-8.26%
EPS past 3/5Y	-37.19% -3.57%
Sales past 3/5Y	-14.56% 8.48%
EPS Y/Y TTM	-59.71%
Sales Y/Y TTM	-0.21%
EPS Q/Q	-108.60%
Sales Q/Q	2.60%
Earnings	Nov 03 BMO
EPS/Sales Surpr.	12.87% 4.41%

Insider Own	0.09%
Insider Trans	2.18%
Inst Own	69.71%
Inst Trans	-0.48%
ROA	2.13%
ROE	4.99%
ROIC	2.97%
Gross Margin	64.83%
Oper. Margin	26.57%
Profit Margin	6.80%
SMA20	5.52%
SMA50	7.21%
SMA200	13.15%
Trades

Shs Outstand	5.70B
Shs Float	5.69B
Short Float	2.64%
Short Ratio	4.33
Short Interest	150.22M
52W High	29.88 0.77%
52W Low	23.62 27.48%
Volatility	1.83% 1.85%
ATR (14)	0.56
RSI (14)	72.56
Beta	0.27
Rel Volume	0.99
Avg Volume	34.69M
Volume	34,396,861

Perf Week	6.13%
Perf Month	8.54%
Perf Quarter	21.31%
Perf Half Y	10.25%
Perf YTD	20.92%
Perf Year	21.95%
Perf 3Y	-1.76%
Perf 5Y	-29.65%
Perf 10Y	-2.36%
Recom	2.62
Target Price	28.99
Prev Close	29.44
Price	30.11
Change %	2.28%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-06-26	Downgrade	HSBC Securities	Buy → Hold	$28
Jun-10-26	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$25
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39

Show Previous Ratings

Today 06:03PM	Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors (Exec Edge)
02:53PM	Wall Street rises with investors rotating into healthcare and value stocks (Reuters)
Oct-17-26 12:15PM	Pfizer or Kraft Heinz: Only One Gets My Dividend Dollars for the Next 10 Years (TIKR)
Oct-16-26 10:57PM	What Was Eli Lilly Telling You Before Its Stock Ran? (Trefis)
08:53PM	When Amgen's Forecast And Chart Say The Same Thing, Pay Attention (Trefis)
08:37PM	Loading…
08:37PM	Gileads HIV Prevention Business Just Topped $1 Billion A Quarter. What Comes Next? (Trefis)
08:13PM	Is Amgen Stock Increasing Your Market Risk? (Trefis)
10:44AM	What Is The Case For Waiting On Moderna Stock? (Trefis)
Oct-15-26 03:59PM	Better Dividend Stock: Pfizer vs. GSK (TIKR)
03:46PM	How Has Merck's Story Changed? (Trefis)
09:09AM	Where Could Johnson & Johnson's Next Growth Come From? (Trefis)
05:30AM	Big Pharma Is Pouring Billions Into a New Class of 'Protein Degrader' Drugs (The Wall Street Journal)
Oct-14-26 11:47PM	Why Did GME, BMBL, PFE Stocks Hit 52-Week Highs Today? (Stocktwits)
09:47PM	How Much Downside Is Left In Liquidia Stock? (Trefis)
05:45PM	What Could Send Regeneron Stock Higher? (Trefis)
03:34PM	Loading…
03:34PM	Better High-Yield Dividend Stock: Pfizer vs. General Mills (TIKR)
03:25PM	Better High-Yield Dividend Stock: Pfizer vs. British American Tobacco (TIKR)
03:12PM	Better High-Yield Dividend Stock: Pfizer vs. UPS (TIKR)
03:01PM	Better High-Yield Dividend Stock: Pfizer vs. Healthpeak (TIKR)
02:40PM	Better High-Yield Dividend Stock: Pfizer vs. Edison International (TIKR)
02:34PM	Better High-Yield Dividend Stock: Pfizer vs. Clorox (TIKR)
09:31AM	J&J earnings set negative tone; Shkreli vs. the FTC (BioPharma Dive)
08:18AM	The Open Question Under Johnson & Johnson Stock's Price (Trefis)
06:45AM	Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026 (Business Wire)
06:39AM	Pfizer partners with Enodia Therapeutics in $500m drug deal (Pharmaceutical Business Review)
Oct-13-26 07:48PM	Is Amgen Stock Worth More Than Its Competitors? (Trefis)
04:20PM	Pfizer or Enbridge: Only One Gets My Dividend Dollars for the Next 10 Years (TIKR)
03:59PM	What Does Bristol-Myers Squibb Offer That Pfizer Does Not? (Trefis)
03:24PM	What Is Eli Lilly Stock's Biggest Opportunity? (Trefis)
03:00AM	Ozempic face powers revival of a fading British giant (The Telegraph)
05:01PM	Loading…
Oct-12-26 05:01PM	Where Could Moderna's Next Growth Come From? (Trefis)
10:15AM	Bristol Myers Stock Is Rising on a Double Dose of Good News (Barrons.com)
Oct-11-26 09:22PM	SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH (Stocktwits)
Oct-10-26 12:06PM	Four Analysts Raised Their Pfizer Targets in One Week Without an Upgrade. Heres Where the Stock Could Go By 2030 (TIKR)
Oct-09-26 08:47PM	Why Is Everyone Ignoring Gilead Stock's High Cash Yield? (Trefis)
08:09PM	BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits)
04:13PM	Moderna stock hits 4-year high on planned national cancer vaccine effort (Yahoo Finance)
03:39PM	Top Research Reports for JPMorgan, ASML & Chevron (Zacks)
02:12PM	Does The Move In Merck Stock Change Anything? (Trefis)
12:14PM	Moderna stock jumps on planned national cancer vaccine effort (Yahoo Finance)
11:18AM	FDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts (BioPharma Dive)
Oct-08-26 08:36PM	Should You Be Worried About Pfizer Stock? (Trefis)
08:19PM	What Is Going On With Regeneron Stock? (Trefis)
09:35AM	PFE, LLY, MRK Stocks In Focus: Cantor Raises Price Targets On Pharma Behemoths, But Flags Growth Concerns For Pfizer (Stocktwits)
09:04AM	Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances (Proactive)
09:03AM	What Would It Take For Amgen Stock To Move Higher? (Trefis)
07:07AM	FDA approves Pfizer's Tukysa regimen for metastatic breast cancer (Pharmaceutical Business Review)
Oct-07-26 07:14PM	Is Exelixis Stock Engineered To Make You Money? (Trefis)
12:57PM	Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer (Business Wire)
12:13PM	Why You Should Think About Eli Lilly Stock Differently Now (Trefis)
Oct-06-26 07:30PM	Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 (PR Newswire)
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
10:00AM	Pfizer Declares Fourth-Quarter 2026 Dividend (Business Wire)
08:44AM	Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results (Quartz)
01:38AM	Pfizers $6.49 Billion Prevnar Franchise Faces a New Challenger (TIKR)
Oct-05-26 02:37PM	PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit Blue-Sky Case (Stocktwits)
02:18PM	Drug stocks show rare weakness amid fears of vaccine competition (MarketWatch)
10:43AM	Vaxcyte Soars 36% on Phase 3 Pneumococcal Vaccine Win That Sets a New Benchmark (TIKR)
10:39AM	Vaxcytes stock up after pneumococcal vaccine proves non-inferiority (Clinical Trials Arena)
10:32AM	Vaxcyte shares surge on late-stage vaccine trial success (Proactive)
10:23AM	Vaxcyte Stock Spikes 57% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck (Barrons.com)
10:19AM	Has Eli Lilly Stock Peaked? (Trefis)
10:01AM	Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study (Investor's Business Daily)
09:52AM	Vaxcyte skyrockets on near best-case pneumococcal vaccine data (BioPharma Dive)
07:57AM	EADV26: Key late-stage readouts from the conference (Clinical Trials Arena)
Oct-02-26 11:37AM	Pfizers Eczema Drug Hit a 61% Response Rate the Day Florida Sued. Heres What It Means for the Stock (TIKR)
11:15AM	Pfizer's LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo (Business Wire)
06:27AM	How Has Pfizer's Story Changed? (Trefis)
Oct-01-26 01:09PM	Pfizer Scores Promising Win for Experimental Eczema Drug (GuruFocus.com)
11:41AM	What Is The Options Market Telling Us About Eli Lilly Stock? (Trefis)
02:30AM	Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study (Business Wire)
Sep-30-26 03:01PM	Was The Run In JNJ Stock Hiding In Plain Sight? (Trefis)
12:19PM	Invivyds Covid-directed mAb hits Phase III safety goals (Clinical Trials Arena)
11:34AM	PFE vs. BMY: Each Faces a $22 Billion+ Patent Cliff. One Dividend Looks Much Safer (TIKR)
11:29AM	Are You Overpaying For Pfizer Stock Versus Its Rivals? (Trefis)
10:43AM	What Is Merck Stock's Biggest Opportunity? (Trefis)
Sep-29-26 04:59PM	AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck (Investor's Business Daily)
02:43PM	Is Eli Lilly Stock a Good Fit For Your Portfolio Risk? (Trefis)
12:23PM	Management Raised the Bar For Eli Lilly Stock; Does The Chart Agree? (Trefis)
Sep-28-26 04:33PM	$85 Billion And Counting: JNJ Stock's Steady Cash-Return Habit (Trefis)
02:08PM	What Are Merck Stock Investors Overlooking? (Trefis)
10:06AM	BioNTech to Close Manufacturing Sites in Germany and Singapore After Sale Process Ends (InvestorsHub)
08:50AM	What Bavarian Nordics next CEO is up against (Pharma Voice)
06:45AM	Pfizer Advances Today's Cancer Care and Tomorrow's Potential Breakthroughs at ESMO (Business Wire)
Sep-27-26 08:46AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-25-26 01:13PM	Is LLY Stock Cheaper Than It Looks? (Trefis)
01:03PM	Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money? (Trefis)
11:39AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-24-26 03:03PM	Can Eli Lilly Stock Catch Up To Rivals It Outgrows? (Trefis)
Sep-23-26 01:18PM	What Is AbbVie No Longer Telling You? (Trefis)
12:53PM	Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next (Barrons.com)
12:37PM	What Is The Best Case For Pfizer Stock? (Trefis)
10:39AM	Pfizers International Chief Just Explained How the Turnaround Actually Works. Heres Where the Stock Could Go (TIKR)
Sep-22-26 01:39PM	Was Moderna Stock's Cancer Vaccine Run Visible In Advance? (Trefis)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts (Business Wire)
09:50AM	Could You Have Seen Merck Stock's Pipeline Run Coming? (Trefis)
09:40AM	Why Is JNJ Stock Beating Rivals That Grow Faster? (Trefis)
Sep-21-26 12:43PM	NYC Office-to-Residential Conversions Keep Gaining Steam (CRE Daily)
10:40AM	Huge News For Pfizer Stock Fans (GuruFocus.com)
10:17AM	What Would It Take For Pfizer To Cut Its Dividend? (Trefis)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Aug 12 '26	Buy	26.34	38,000	1,000,920	429,173	Aug 12 04:04 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 05 '26	Sale	25.40	3,278	83,261	28,611	Aug 06 11:26 AM
BLAYLOCK RONALD E	Director	Aug 05 '26	Buy	25.46	39,231	998,821	66,938	Aug 05 04:03 PM
Buckley Mortimer J	Director	Aug 05 '26	Buy	25.52	37,632	960,369	37,632	Aug 05 04:02 PM
DAMICO JENNIFER B.	SVP & Controller	Jun 09 '26	Sale	25.70	2,000	51,400	31,397	Jun 10 07:58 PM
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Ph.D.Dr. Albert Bourla D.V.M.

M.D.Dr. Chris Boshoff FMedSci

Executive VP & Chief Legal OfficerMr. Douglas M. Lankler

Executive VP & Chief U.S. Commercial OfficerMr. Aamir Malik

Interim CFO & Executive VPMs. Cecile Guegan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your Finviz experience